Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses
Research and development	$ 2,278,424	$ 1,842,803
General and administrative	4,603,514	1,365,214
Total operating expenses	6,881,938	3,208,017
Loss from operations	(6,881,938)	(3,208,017)
Other income (expenses)
Interest expense	(1,591,244)	(831,277)
Change in redemption value		1,832,651
Total other income (expenses), net	(1,591,244)	1,001,374
Net loss	$ (8,473,182)	$ (2,206,643)
Net loss per share
Basic and diluted	$ (0.75)	$ (0.35)
Weighted average number of common shares outstanding:
Basic and diluted	11,316,804	6,357,314